Display options
Cite
Panicek DM, Hilton S, Schwartz LH. Assessment of neurovascular involvement by malignant musculoskeletal tumors. Sarcoma. 1997;1(1):61-3doi: 10.1080/13577149778506.
Panicek, D. M., Hilton, S., & Schwartz, L. H. (1997). Assessment of neurovascular involvement by malignant musculoskeletal tumors. Sarcoma, 1(1), 61-3. https://doi.org/10.1080/13577149778506
Panicek, D M, et al. "Assessment of neurovascular involvement by malignant musculoskeletal tumors." Sarcoma vol. 1,1 (1997): 61-3. doi: https://doi.org/10.1080/13577149778506
Panicek DM, Hilton S, Schwartz LH. Assessment of neurovascular involvement by malignant musculoskeletal tumors. Sarcoma. 1997;1(1):61-3. doi: 10.1080/13577149778506. PMID: 18521203; PMCID: PMC2373581.
Copy Download .nbib Format: NLM
Share it on

Sarcoma. 1997;1(1):61-3. doi: 10.1080/13577149778506.

Assessment of neurovascular involvement by malignant musculoskeletal tumors.

Sarcoma

D M Panicek, S Hilton, L H Schwartz

Affiliations

  1. Department of Radiology Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York NY 10021 USA.

PMID: 18521203 PMCID: PMC2373581 DOI: 10.1080/13577149778506

Abstract

Determining the presence or absence of neurovascular involvement by a malignant musculoskeletal neoplasm is an important aspect of local tumor staging. This article discusses issues concerning such assessments made by diagnostic imaging techniques, including factors inherent to the patient and those related to imaging technology. The distinction between tumor contact and tumor encasement is emphasized and illustrated.

References

  1. Radiology. 1997 Jan;202(1):237-46 - PubMed
  2. Radiology. 1991 Apr;179(1):247-52 - PubMed
  3. J Bone Joint Surg Am. 1980 Sep;62(6):1027-30 - PubMed
  4. Cancer. 1981 Mar 1;47(5):1005-22 - PubMed
  5. AJR Am J Roentgenol. 1994 Sep;163(3):509-13; discussion 514-6 - PubMed
  6. Radiology. 1987 Jan;162(1 Pt 1):251-5 - PubMed
  7. AJR Am J Roentgenol. 1991 Aug;157(2):347-51 - PubMed

Publication Types